These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37906568)

  • 1. Knowledge and perceptions of lymphatic filariasis patients in selected hotspot endemic communities in southern Ghana.
    Kwarteng A; Kenyon KH; Opoku Asiedu S; Garcia R; Kini P; Osei-Poku P; Kwarteng ES; Amewu EKA
    PLOS Glob Public Health; 2023; 3(10):e0002476. PubMed ID: 37906568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparative Study of Lymphatic Filariasis-Related Perceptions among Treated and Non-Treated Individuals in the Ahanta West Municipality of Ghana.
    Ahorlu CS; Otchere J; Sedzro KM; Pi-Bansa S; Asemanyi-Mensah K; Opare JL; Alomatu B; Long EF; de Souza DK
    Trop Med Infect Dis; 2022 Sep; 7(10):. PubMed ID: 36288014
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential factors influencing lymphatic filariasis transmission in "hotspot" and "control" areas in Ghana: the importance of vectors.
    Pi-Bansa S; Osei JHN; Frempong KK; Elhassan E; Akuoko OK; Agyemang D; Ahorlu C; Appawu MA; Koudou BG; Wilson MD; de Souza DK; Dadzie SK; Utzinger J; Boakye DA
    Infect Dis Poverty; 2019 Feb; 8(1):9. PubMed ID: 30717788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community views on mass drug administration for filariasis: a qualitative evidence synthesis.
    Taylor M; Thomas R; Oliver S; Garner P
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013638. PubMed ID: 35174482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana.
    Biritwum NK; Garshong B; Alomatu B; de Souza DK; Gyapong M; Kyelem D
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005619. PubMed ID: 28493966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial burden impact quality of life among lymphatic Filariasis patients.
    Asiedu SO; Kwarteng A; Amewu EKA; Kini P; Aglomasa BC; Forkuor JB
    BMC Public Health; 2021 Jan; 21(1):174. PubMed ID: 33478462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997-2006.
    Allen T; Taleo F; Graves PM; Wood P; Taleo G; Baker MC; Bradley M; Ichimori K
    Trop Med Health; 2017; 45():8. PubMed ID: 28579911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-compliance to Mass Drug Administration Associated with the Low Perception of the Community Members About their Susceptibility to Lymphatic Filariasis in Ankobra, Ghana.
    Dicko I; Coulibaly YI; Sangaré M; Sarfo B; Nortey PA
    Infect Disord Drug Targets; 2020; 20(2):167-174. PubMed ID: 30727921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fight against lymphatic filariasis: perceptions of community drug distributors during mass drug administration in coastal Kenya.
    Kusi C; Steinmann P; Merten S
    Infect Dis Poverty; 2020 Mar; 9(1):22. PubMed ID: 32114985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continental-scale, data-driven predictive assessment of eliminating the vector-borne disease, lymphatic filariasis, in sub-Saharan Africa by 2020.
    Michael E; Singh BK; Mayala BK; Smith ME; Hampton S; Nabrzyski J
    BMC Med; 2017 Sep; 15(1):176. PubMed ID: 28950862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards elimination of Lymphatic Filariasis in Kenya: improving advocacy, communication and social mobilization activities for mass drug administration, a qualitative study.
    Kibe LW; Kimani BW; Okoyo C; Omondi WP; Sultani HM; Njomo DW
    Trop Dis Travel Med Vaccines; 2022 Jun; 8(1):16. PubMed ID: 35668465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community perspectives on persistent transmission of lymphatic filariasis in three hotspot districts in Ghana after 15 rounds of mass drug administration: a qualitative assessment.
    Ahorlu CSK; Koka E; Adu-Amankwah S; Otchere J; de Souza DK
    BMC Public Health; 2018 Feb; 18(1):238. PubMed ID: 29433461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 6th Meeting of the Global Alliance to Eliminate Lymphatic Filariasis: A half-time review of lymphatic filariasis elimination and its integration with the control of other neglected tropical diseases.
    Addiss D;
    Parasit Vectors; 2010 Oct; 3():100. PubMed ID: 20961435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards Understanding the Microepidemiology of Lymphatic Filariasis at the Community Level in Ghana.
    Sumboh JG; Laryea NA; Otchere J; Ahorlu CS; de Souza DK
    Trop Med Infect Dis; 2024 May; 9(5):. PubMed ID: 38787040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating context-specific evidence-based quality improvement intervention on lymphatic filariasis mass drug administration in Northern Ghana using the RE-AIM framework.
    Manyeh AK; Chirwa T; Ramaswamy R; Baiden F; Ibisomi L
    Trop Med Health; 2021 Feb; 49(1):16. PubMed ID: 33602322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous dynamics, robustness/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasis.
    Michael E; Singh BK
    BMC Med; 2016 Jan; 14():14. PubMed ID: 26822124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines.
    Amarillo ML; Belizario VY; Sadiang-Abay JT; Sison SA; Dayag AM
    Parasit Vectors; 2008 May; 1(1):14. PubMed ID: 18505577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.
    Krentel A; Damayanti R; Titaley CR; Suharno N; Bradley M; Lynam T
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005027. PubMed ID: 27812107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diethylcarbamazine citrate-fortified salt for lymphatic filariasis elimination in India.
    Sabesan S; Krishnamoorthy K; Hoti SL; Subramanian S; Srividya A; Roy N; Jain T; Kumar A; Rahi M
    Indian J Med Res; 2022 Mar; 155(3&4):347-355. PubMed ID: 36124509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.